Journals / Damar Cerrahi Dergisi / 2006 / Cilt: 15 - Sayı: 2

Treatment methods in critical limb ischemia pain

Kritik bacak iskemisi ağrısında tedavi metotları

Pages
1–9
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this paper we will discuss about supportive treatment options in this area and developing treatment methods.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Critical limb ischemia is a clinical pathology with rising incidence characterized by rest pain, persistant wounds at feet, and gangrene.
📊
Key Findings & Data:With the help of various pain treatment protocols, pain is releived, wound healing accelerated, amputation drawn to distal levels, delayed or even prevented.
💡
Conclusion & Impact:In this paper we will discuss about supportive treatment options in this area and developing treatment methods.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Critical limb ischemia is a clinical pathology with rising incidence characterized by rest pain, persistant wounds at feet, and gangrene. Its preventable risk factors are control of hypertension and diabetes mellitus, cessation of smoking and treatment of hyperlipidemia. Treatment steps include preventive therapy, revascularization with surgery and amputation. There are medical therapy and pain therapy schema options with numerous pharmacological agents for patients before surgery and when surgery is not possible. With the help of various pain treatment protocols, pain is releived, wound healing accelerated, amputation drawn to distal levels, delayed or even prevented. In this paper we will discuss about supportive treatment options in this area and developing treatment methods.

Özet

Kritik bacak iskemisi istirahat ağrısı, ayakta iyileşmeyen yaralar ve gangrenle sonuçlanan, toplumda görülme sıklığı giderek artış gösteren klinik patolojidir. Önlenebilir risk faktörleri; diyabet ve hipertansiyonun kontrolü, sigaranın bıraktırılması ve hiperlipidemi tedavisidir. Tedavi, koruyucu tedavi, cerrahi ile revaskülarizasyon tedavisi ve amputasyon aşamalarını içerir. Cerrahi tedavi öncesi ve cerrahi tedavinin mümkün olmadığı hastalarda çeşitli farmakolojik ajanlardan oluşan medikal tedavi ve ağrı tedavi şemaları uygulanmaktadır. Çeşitli ağrı tedavi protokollerinin uygulanmasıyla ağrı giderilmekte, yara iyileşmesi hızlanmakta, yürüyüş mesafesi uzamakta, amputasyon seviyesi distale çekilmekte veya geciktirilmekte, hatta amputasyon önlenmektedir. Bu yazıda bu konudaki destekleyici tedavi seçenekleri ve üzerinde çalışılmakta olan tedavi metotları tartışılacaktır.

🔖

Cite This Article

AYKAÇ, Z., ÇORUH, T., SÜZER, A. (2022). Treatment methods in critical limb ischemia pain. Damar Cerrahi Dergisi, Cilt: 15 - Sayı: 2, 1–9. https://ajindex.com/articles/486854

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Steven Dean, Vaccaro SP. Successful pharmacologic treatment of lower extermity ulcerations in 5 patients with chronic critical limb ischemia. JABFP jan-feb 2002;15(1):55-62
  2. Catalano M. Epidemiology of critical limb ischemia: North Italian data. Eur J Med. 1993; 2(1):11-4
  3. Kummer O, Widmer MK, Pluss S et al. Does infection affect amputation rate in chronic critical leg ischemia. Vasa. 2003;32(1):18-21
  4. Bendermacher BLW, Willigendael EM, Teijink JAW, Prins MH. Medical management of peripheral arterial disease. JThromb Haemost. 2005; 3(8):1628-1637
  5. Bendermacher BL, Willigendael EM, Teijink JA, Prins MH. Medical management of peripheral arterial disease. J Tromb Haemost. 2005;3(8):1628-37
  6. Santilli JD, Santilli SM. Chronic critical limb Ischemia: Diagnosis, treatment and prognosis. Am Fam Physician 1999;59(7):1899-908
  7. Samuel Money, W Charles Sternberg, Medical treatment of intermittent claudication.In: Vascular Surgery, Rutherford, 6th ed, volume one. Pennsylvania, Elsevier Saunders, Inc., 2005: 602-6
  8. The European Study Group. Intravenous pentoxifylline for the treatment of chronic critical limb ischaemia. Eur J Vasc Endovasc Surg. 1995; 9(4): 426-36
  9. Dean SM. Pharmacologic treatment for intermittent claudication. Vasc Med. 2002; 7(4):301-9. 10.Centrorrino T, Versaci A, Ciccolo A et al. Our experience in using a synthetic prostacyclin analog in the treatment of critical ischemia of the extremities. G Chir. 1998; 19(10): 399-403. 11.U.K. Severe Limb Ischaemia Study Group. Treatment of limb threateing ischaemia with intravenous iloprost: a randomised double-blind placebo controlled study. Eur J Vasc Surg 1991;5:511-516. 12.Stricker H, Kaiser U, Frei J, Mahler F. Acute and long-term effects of prostaglandin E1 assessed by clinical and microcirculatory parameters in critical limb ischemia: a pilot study. Int J Microcirc Clin Exp. 1996;16(2): 57-63., 13. Cooke JP, Bhatnagar R, Szuba A, Rockson SG. Fibroblast growth factor as therapy for critical limb ischemia: a case report. Vasc Med. 1999;4(2):89-91. 14.CAPR‹E Steering Committee: A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPR‹E). Lancet 1996; 348:1329-39. 15.Clifford J. Woolf, Mitchell B. Max. Mechanism-based pain diagnosis. Issues for analgesic drug development. Anesthesiology 2001; 95:241-9. Dr. Asuman Süzer ve Arkadaßlar› Damar Cer Derg 2006; 15 (2): 1-98 16.Carl C Hug Jr. Pain Management. Morgan GE, Mikhail MS, Murray MJ(e